Measurement of circulatory unhydrolysed mycophenolate mofetil (MMF) to mycophenolic acid (MPA) with intravenous MMF in post liver transplant patients.

被引：0
|
作者：
Jain, Ashok
Mohanka, Ravi
Tai, Kwong
Orloff, Mark
Abt, Peter
Bozorgzadeh, Adel
机构：
[1] Univ Rochester, Med Ctr, Div Transplantat, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Biochem, Rochester, NY 14642 USA
来源：
LIVER TRANSPLANTATION | 2006年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：C125 / C125
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics (PK) of intravenous mycophenolate mofetil (MMF) in liver transplant patients.
    Hebert, MF
    Chang, T
    Linna, TJ
    Hale, MD
    Roberts, JP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI101 - PI101
  • [2] Monitoring mycophenolic acid (MPA) plasma levels may benefit the management of liver transplant recipients treated with mycophenolate mofetil (MMF).
    Brown, NW
    Gonde, C
    Adams, J
    Tredger, JM
    [J]. THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 513 - 513
  • [3] Mycophenolate mofetil (MMF) in pediatric liver transplant recipients
    Dhawan, A
    Lewis, PN
    Heaton, ND
    Baker, AJ
    Rela, M
    Hadzic, N
    Srinivasan, P
    MieliVergani, G
    [J]. HEPATOLOGY, 1997, 26 (04) : 1487 - 1487
  • [4] Pharmacokinetics (PK) and pharmacodynamics (PD) of mycophenolic acid (MPA) in stable renal transplant recipients treated with suboptimal doses of mycophenolate mofetil (MMF)
    Brunet, M
    Martorell, J
    Oppenheimer, F
    Vilardell, J
    Millán, O
    Carrillo, M
    Corbella, J
    [J]. TRANSPLANTATION, 1999, 67 (07) : S205 - S205
  • [5] Sequential determination of pharmacokinetics (PK) and pharmacodynamics (PD) of mycophenolate mofetil (MMF) in liver transplant (LT) patients.
    Brunet, M
    Martorell, J
    Vidal, E
    Jimenez, O
    Millan, O
    Rojo, I
    Cirera, I
    Rimola, A
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 528 - 529
  • [6] Mycophenolic acid (MPA) AUC(0-12H) in stable liver transplant patients treated with a monotherapy of mycophenolate mofetil (MMF) for calcineurin inhibitors (CNI) induced nephrotoxicity
    Dharancy, Sebastien
    Hulin, Anne
    Declerck, Nicole
    Blanchet, Benoiet
    Boleslawski, Emmanuel
    Canva, Valerie
    Mathurin, Philippe
    Pruvot, Francois-Rene
    [J]. HEPATOLOGY, 2006, 44 (04) : 406A - 407A
  • [7] Mycophenolate mofetil (MMF) for the treatment of acute and chronic GVHD in bone marrow transplant patients.
    Basara, N
    Blau, W
    Romer, E
    Rudolphi, M
    Bishoff, M
    Kirsten, D
    Sanchez, H
    Gunzelmann, S
    Fauser, AA
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 548 - 548
  • [8] Mycophenolic acid (MPA) AUC(0-12h) in stable liver transplant patients treated with a monotherapy of mycophenolate mofetil (MMF) for calcineurin inhibitors (CNI) induced nephrotoxicity
    Dharancy, S.
    Hulin, A.
    Declerck, N.
    Blanchet, B.
    Boleslawski, E.
    Canva, V.
    Mathurin, P.
    Pruvot, F. R.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S68 - S68
  • [9] Does mofetil mycophenolate (MMF) delay hepatitis C recurrence in liver transplant patients?
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Molmenti, EP
    Klintmalm, GB
    [J]. TRANSPLANTATION, 2000, 69 (08) : S120 - S120
  • [10] Mycophenolate mofetil (MMF) versus azathioprine (AZA) in a large registry of pediatric renal transplant patients.
    Steffen, B
    Gotz, V
    Chu, A
    Gordon, R
    Morris, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 651A - 651A
12345